These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7927470)

  • 21. Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.
    Kim S; Jang JE; Yu JR; Chang J
    Vaccine; 2010 May; 28(22):3801-8. PubMed ID: 20362203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The specific activity and immunological safety of the intranasal method of revaccination with a live measles vaccine made from the Leningrad-16 strain].
    Iuminova NV; Krasnova VP; Liashenko VA; Vedunova SL
    Vopr Virusol; 1993; 38(3):111-3. PubMed ID: 7521099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis.
    Brinckmann UG; Bankamp B; Reich A; ter Meulen V; Liebert UG
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2491-500. PubMed ID: 1833505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antibody response to different measles virus antigens under various conditions of immunization.
    Norrby E; Salmi AA; Vandvik B; Hammarskjöld B; Panelius M
    Adv Exp Med Biol; 1972; 31(0):49-69. PubMed ID: 4212389
    [No Abstract]   [Full Text] [Related]  

  • 25. Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector.
    Fennelly GJ; Khan SA; Abadi MA; Wild TF; Bloom BR
    J Immunol; 1999 Feb; 162(3):1603-10. PubMed ID: 9973419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice.
    de Vries P; van Binnendijk RS; van der Marel P; van Wezel AL; Voorma HO; Sundquist B; Uytdehaag FG; Osterhaus AD
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():549-59. PubMed ID: 3258355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralizing B cell response in measles.
    Bouche FB; Ertl OT; Muller CP
    Viral Immunol; 2002; 15(3):451-71. PubMed ID: 12479395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
    Bessa J; Schmitz N; Hinton HJ; Schwarz K; Jegerlehner A; Bachmann MF
    Eur J Immunol; 2008 Jan; 38(1):114-26. PubMed ID: 18081037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A trial of the intranasal vaccination of adults against measles: the approaches to an alternative revaccination method].
    Liashenko VA; Iuminova NV; Krasnova VP
    Vopr Virusol; 1992; 37(2):107-9. PubMed ID: 1441428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Migration of antigen-presenting B cells from peripheral to mucosal lymphoid tissues may induce intestinal antigen-specific IgA following parenteral immunization.
    Coffin SE; Clark SL; Bos NA; Brubaker JO; Offit PA
    J Immunol; 1999 Sep; 163(6):3064-70. PubMed ID: 10477570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
    Olszewska W; Obeid OE; Steward MW
    Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation.
    Buonaguro L; Visciano ML; Tornesello ML; Tagliamonte M; Biryahwaho B; Buonaguro FM
    J Virol; 2005 Jun; 79(11):7059-67. PubMed ID: 15890945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measles antibodies in nasal secretions and sera of children with measles.
    Polna I; Aleksandrowicz J; Krawczyński K; Krotochwil-Skrzypek M; Rozskowska K
    Acta Virol; 1977 Jul; 21(4):331-7. PubMed ID: 20768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diploid cell measles vaccine.
    Fernández de Castro J; Valdespino Gómez JL; Díaz Ortega JL; Zárate Aquino ML
    JAMA; 1986 Aug; 256(6):714. PubMed ID: 3606740
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies.
    Ong HT; Hasegawa K; Dietz AB; Russell SJ; Peng KW
    Gene Ther; 2007 Feb; 14(4):324-33. PubMed ID: 17051248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody.
    Premenko-Lanier M; Rota PA; Rhodes GH; Bellini WJ; McChesney MB
    J Infect Dis; 2004 Jun; 189(11):2064-71. PubMed ID: 15143474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
    Arrouji A; Mirchamsy H; Marnissi A
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
    Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
    Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of systemic immune responses to measles virus synthetic peptides administered intranasally.
    Hathaway LJ; Partidos CD; Vohra P; Steward MW
    Vaccine; 1995 Nov; 13(16):1495-500. PubMed ID: 8578832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.